Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
CC transcript

Cardiogenesis Corp (CGCP) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/19/2011 4 CRYOLIFE INC (10% Owner) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Bought 23,401,043 shares @ $0.457, valued at $10.7M
05/18/2011 4 SLEPIAN MARVIN (Director) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 22,500 options to buy @ $0.8, valued at $18k
Disposed/sold 7,500 options to buy @ $0.54, valued at $4.1k
Disposed/sold 7,500 options to buy @ $0.59, valued at $4.4k
Disposed/sold 7,500 options to buy @ $0.25, valued at $1.9k
Disposed/sold 7,500 options to buy @ $0.29, valued at $2.2k
Disposed/sold 50,000 options to buy @ $0.22, valued at $11k
Disposed/sold 50,000 options to buy @ $0.38, valued at $19k
Disposed/sold 100,000 options to buy @ $0.59, valued at $59k
05/17/2011 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
05/17/2011 4 LANIGAN RICHARD P (Executive VP, Marketing) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 231,895 shares @ $0
Disposed/sold 13,890 options to buy @ $1.01, valued at $14k
Disposed/sold 22,917 options to buy @ $0.91, valued at $20.9k
Disposed/sold 14,583 options to buy @ $0.91, valued at $13.3k
Disposed/sold 11,110 options to buy @ $1.01, valued at $11.2k
Disposed/sold 74,332 options to buy @ $0.32, valued at $23.8k
Disposed/sold 58,802 options to buy @ $0.32, valued at $18.8k
Disposed/sold 83,333 options to buy @ $0.7, valued at $58.3k
Disposed/sold 16,667 options to buy @ $0.7, valued at $11.7k
Disposed/sold 50,000 options to buy @ $1.03, valued at $51.5k
Disposed/sold 75,000 options to buy @ $0.54, valued at $40.5k
05/17/2011 4 COHEN RAYMOND W (Director) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 22,500 options to buy @ $0.18, valued at $4.1k
Disposed/sold 50,000 options to buy @ $0.38, valued at $19k
05/17/2011 4 WALLER GREGORY D (Director) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 22,500 options to buy @ $0.3, valued at $6.8k
Disposed/sold 7,500 options to buy @ $0.29, valued at $2.2k
Disposed/sold 50,000 options to buy @ $0.22, valued at $11k
Disposed/sold 50,000 options to buy @ $0.38, valued at $19k
05/17/2011 4 ABBOTT WILLIAM R (Senior VP, CFO) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 66,038 shares @ $0
Disposed/sold 100,000 options to buy @ $0.49, valued at $49k
Disposed/sold 100,000 options to buy @ $0.3, valued at $30k
Disposed/sold 175,000 options to buy @ $0.13, valued at $22.8k
05/17/2011 4 Sabahat Ann T (Director) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 22,500 options to buy @ $0.28, valued at $6.3k
Disposed/sold 50,000 options to buy @ $0.22, valued at $11k
Disposed/sold 50,000 options to buy @ $0.38, valued at $19k
05/17/2011 4 MCCORMICK PAUL (Executive Chairman) has filed a Form 4 on Cardiogenesis Corp /CA
Txns: Disposed/sold 978,926 shares @ $0
Disposed/sold 22,500 options to buy @ $0.33, valued at $7.4k
Disposed/sold 7,500 options to buy @ $0.29, valued at $2.2k
Disposed/sold 50,000 options to buy @ $0.22, valued at $11k
Disposed/sold 100,000 options to buy @ $0.38, valued at $38k
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/17/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 10-Q Quarterly Report for the period ended March 31, 2011
05/11/2011 3 Form 3 - Initial statement of beneficial ownership of securities
05/11/2011 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/10/2011 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
05/09/2011 EFFECT Form EFFECT - Notice of Effectiveness
05/09/2011 EFFECT Form EFFECT - Notice of Effectiveness
05/06/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/05/2011 8-K Quarterly results
05/05/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/05/2011 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
04/29/2011 10-K/A Annual Report for the period ended December 31, 2010 [amend]
04/18/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation"
04/18/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/15/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Amended and Restated Agreement and Plan of Merger, by and between the Company, Parent and Merger Sub",
"CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation"
04/15/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/12/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/12/2011 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition
04/05/2011 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy